intranasal glutathione in parkinson& 39 delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties Targets to Search for New
Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single Neuron Degeneration Model Intranasal Delivery of Metabolically Resilient Glutathione: In Vivo Pharmacokinetic, Permeation, and Efficacy Studies Molecular Pharmaceutics Intranasal delivery of rotigotine to the brain for treating Parkinson's disease ScienceDirect Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy PMC
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



